In a clinical setting, 302 patients who received Ebselen within 48 h from stroke onset and continued for 2 weeks showed a slightly better outcome at 1 month, but the difference between the active and placebo arm at 3 months failed to reach statistical significance [ 175 ].
← all excerpts
Oxidative Stress in Ischemia/Reperfusion Injuries following Acute Ischemic Stroke.
1
—
—